Advertisement
Steven J. Cagnetta, Esq, and Steven K. Ladd of Primacea describe the problems and pathways for physicians to m...
A description of initiatives designed to expedite the review process.
AdvaMed’s Code of Ethics seeks to provide physicians and industry with the room to collaborate while assurin...
Spurring the next wave of superficial venous disease therapies.
An expert vascular surgeon details his approaches to managing type II endoleaks and asymptomatic carotid arter...
The history behind absolute ethanol as an intravascular embolic agent, its mechanism of action, and applicatio...
The latest innovations in outflow treatment devices are expanding options for a growing CLI patient population...
Weighing clinical benefits along with cost when selecting therapies is more important than ever.
Understanding the design elements of interventional guidewires is the basis for successful use.
Advertisement
North Brunswick, NJ - Part-time
Houston, TX - Full-time
Strategic Marketing Specialist
Flagstaff, AZ - Full-time
Physicians' experiences and opinions of the Zenith Fenestrated AAA endovascular graft. more >
From materials to referrals, a look at what's driving today's practice patterns. more >
The 2013 edition of the Buyer's Guide, your comprehensive resource for up-to-date information on current technologies for treating vascular disease. more >
The 2013 edition of the Buyer's Guide, your comprehensive resource for up-to-date information on current technologies for treating vascular disease. more >
All of EVToday.com's news items and feature articles on thoracic aortic intervention in one convenient place.
Featured Channel: Thoracic >
Free classified listings for job opportunities in the vascular field, from clinical to industry positions.
Jobs Marketplace >Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.